Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1995-10-18
1997-05-13
Springer, David B.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514456, 514561, 514564, 514563, 546147, 549398, 562490, 558 11, A61K 3119, A61K 3135, A61K 3147, C07D21716, C07D30922, C07C 6336
Patent
active
056293216
ABSTRACT:
The invention relates to a novel compound which is represented by the formula (1) and has an excellent platelet aggregation inhibiting action based on fibrinogen antagonism. The platelet aggregation inhibitor containing the compound of the formula (1) as an effective ingredient are effective for prevention and curing of thrombosis and restenosis or reocclusion after percutaneous transluminal coronary angioplasty or percutaneous transluminal coronary recanalization.
REFERENCES:
Cook et al, Platelet Glycoprotein IIb/IIIa Antagonists, Drugs of the Future, vol. 19, No. 2, pp. 135-159, 1994.
Kibayashi Kenji
Miyamoto Michihiko
Okumura Kunio
Shimazaki Toshiyuki
Yamashita Hiroyuki
Mitsui Toatsu Chemicals Inc.
Springer David B.
LandOfFree
Bicyclic compound and platelet aggregation inhibitor containing does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Bicyclic compound and platelet aggregation inhibitor containing , we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Bicyclic compound and platelet aggregation inhibitor containing will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1385591